REPORT ID 6277

EMEA (Europe, Middle East and Africa) Transmembrane Prolyl 4 Hydroxylase Market Report 2017

Publish Date
25-Dec-17
Pages
108
Format
Electronic (PDF)

In this report, the EMEA Transmembrane Prolyl 4 Hydroxylase market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Pcs), revenue (Million USD), market share and growth rate of Transmembrane Prolyl 4 Hydroxylase for these regions, from 2012 to 2022 (forecast)
    Europe: Germany, France, UK, Russia, Italy and Benelux;
    Middle East: Saudi Arabia, Israel, UAE and Iran;
    Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Transmembrane Prolyl 4 Hydroxylase market competition by top manufacturers/players, with Transmembrane Prolyl 4 Hydroxylase sales volume (K Pcs), price (USD/Pcs), revenue (Million USD) and market share for each manufacturer/player; the top players including
    Bayer AG
    FibroGen Inc
    GlaxoSmithKline Plc
    Japan Tobacco Inc
    Sigmoid Pharma Ltd
    Merck & Co., Inc.
    Akebia Therapeutics, Inc.
    ...

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into
    Daprodustat
    Dimethyloxalylglycine
    FG-2216
    FG-4497
    Others

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Anemia
    Inflammatory Bowel Disease
    Brain Edema
    Colitis
    Others

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

EMEA (Europe, Middle East and Africa) Transmembrane Prolyl 4 Hydroxylase Market Report 2017
1 Transmembrane Prolyl 4 Hydroxylase Overview
    1.1 Product Overview and Scope of Transmembrane Prolyl 4 Hydroxylase
    1.2 Classification of Transmembrane Prolyl 4 Hydroxylase
        1.2.1 EMEA Transmembrane Prolyl 4 Hydroxylase Market Size (Sales) Comparison by Type (2012-2022)
        1.2.2 EMEA Transmembrane Prolyl 4 Hydroxylase Market Size (Sales) Market Share by Type (Product Category) in 2016
        1.2.3 Daprodustat
        1.2.4 Dimethyloxalylglycine
        1.2.5 FG-2216
        1.2.6 FG-4497
        1.2.7 Others
    1.3 EMEA Transmembrane Prolyl 4 Hydroxylase Market by Application/End Users
        1.3.1 EMEA Transmembrane Prolyl 4 Hydroxylase Sales (Volume) and Market Share Comparison by Application (2012-2022
        1.3.2 Anemia
        1.3.3 Inflammatory Bowel Disease
        1.3.4 Brain Edema
        1.3.5 Colitis
        1.3.6 Others
    1.4 EMEA Transmembrane Prolyl 4 Hydroxylase Market by Region
        1.4.1 EMEA Transmembrane Prolyl 4 Hydroxylase Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 Europe Status and Prospect (2012-2022)
        1.4.3 Middle East Status and Prospect (2012-2022)
        1.4.4 Africa Status and Prospect (2012-2022)
    1.5 EMEA Market Size (Value and Volume) of Transmembrane Prolyl 4 Hydroxylase (2012-2022)
        1.5.1 EMEA Transmembrane Prolyl 4 Hydroxylase Sales and Growth Rate (2012-2022)
        1.5.2 EMEA Transmembrane Prolyl 4 Hydroxylase Revenue and Growth Rate (2012-2022)

2 EMEA Transmembrane Prolyl 4 Hydroxylase Competition by Manufacturers/Players/Suppliers, Region, Type and Application
    2.1 EMEA Transmembrane Prolyl 4 Hydroxylase Market Competition by Players/Manufacturers
        2.1.1 EMEA Transmembrane Prolyl 4 Hydroxylase Sales Volume and Market Share of Major Players (2012-2017)
        2.1.2 EMEA Transmembrane Prolyl 4 Hydroxylase Revenue and Share by Players (2012-2017)
        2.1.3 EMEA Transmembrane Prolyl 4 Hydroxylase Sale Price by Players (2012-2017)
    2.2 EMEA Transmembrane Prolyl 4 Hydroxylase (Volume and Value) by Type/Product Category
        2.2.1 EMEA Transmembrane Prolyl 4 Hydroxylase Sales and Market Share by Type (2012-2017)
        2.2.2 EMEA Transmembrane Prolyl 4 Hydroxylase Revenue and Market Share by Type (2012-2017)
        2.2.3 EMEA Transmembrane Prolyl 4 Hydroxylase Sale Price by Type (2012-2017)
    2.3 EMEA Transmembrane Prolyl 4 Hydroxylase (Volume) by Application
    2.4 EMEA Transmembrane Prolyl 4 Hydroxylase (Volume and Value) by Region
        2.4.1 EMEA Transmembrane Prolyl 4 Hydroxylase Sales and Market Share by Region (2012-2017)
        2.4.2 EMEA Transmembrane Prolyl 4 Hydroxylase Revenue and Market Share by Region (2012-2017)
        2.4.3 EMEA Transmembrane Prolyl 4 Hydroxylase Sales Price by Region (2012-2017)

3 Europe Transmembrane Prolyl 4 Hydroxylase (Volume, Value and Sales Price), by Players, Countries, Type and Application
    3.1 Europe Transmembrane Prolyl 4 Hydroxylase Sales and Value (2012-2017)
        3.1.1 Europe Transmembrane Prolyl 4 Hydroxylase Sales Volume and Growth Rate (2012-2017)
        3.1.2 Europe Transmembrane Prolyl 4 Hydroxylase Revenue and Growth Rate (2012-2017)
    3.2 Europe Transmembrane Prolyl 4 Hydroxylase Sales and Market Share by Type
    3.3 Europe Transmembrane Prolyl 4 Hydroxylase Sales and Market Share by Application
    3.4 Europe Transmembrane Prolyl 4 Hydroxylase Sales Volume and Value (Revenue) by Countries
        3.4.1 Europe Transmembrane Prolyl 4 Hydroxylase Sales Volume by Countries (2012-2017)
        3.4.2 Europe Transmembrane Prolyl 4 Hydroxylase Revenue by Countries (2012-2017)
        3.4.3 Germany Transmembrane Prolyl 4 Hydroxylase Sales and Growth Rate (2012-2017)
        3.4.4 France Transmembrane Prolyl 4 Hydroxylase Sales and Growth Rate (2012-2017)
        3.4.5 UK Transmembrane Prolyl 4 Hydroxylase Sales and Growth Rate (2012-2017)
        3.4.6 Russia Transmembrane Prolyl 4 Hydroxylase Sales and Growth Rate (2012-2017)
        3.4.7 Italy Transmembrane Prolyl 4 Hydroxylase Sales and Growth Rate (2012-2017)
        3.4.8 Benelux Transmembrane Prolyl 4 Hydroxylase Sales and Growth Rate (2012-2017)

4 Middle East Transmembrane Prolyl 4 Hydroxylase (Volume, Value and Sales Price), by Region, Type and Application
    4.1 Middle East Transmembrane Prolyl 4 Hydroxylase Sales and Value (2012-2017)
        4.1.1 Middle East Transmembrane Prolyl 4 Hydroxylase Sales Volume and Growth Rate (2012-2017)
        4.1.2 Middle East Transmembrane Prolyl 4 Hydroxylase Revenue and Growth Rate (2012-2017)
    4.2 Middle East Transmembrane Prolyl 4 Hydroxylase Sales and Market Share by Type
    4.3 Middle East Transmembrane Prolyl 4 Hydroxylase Sales and Market Share by Application
    4.4 Middle East Transmembrane Prolyl 4 Hydroxylase Sales Volume and Value (Revenue) by Countries
        4.4.1 Middle East Transmembrane Prolyl 4 Hydroxylase Sales Volume by Countries (2012-2017)
        4.4.2 Middle East Transmembrane Prolyl 4 Hydroxylase Revenue by Countries (2012-2017)
        4.4.3 Saudi Arabia Transmembrane Prolyl 4 Hydroxylase Sales and Growth Rate (2012-2017)
        4.4.4 Israel Transmembrane Prolyl 4 Hydroxylase Sales and Growth Rate (2012-2017)
        4.4.5 UAE Transmembrane Prolyl 4 Hydroxylase Sales and Growth Rate (2012-2017)
        4.4.6 Iran Transmembrane Prolyl 4 Hydroxylase Sales and Growth Rate (2012-2017)

5 Africa Transmembrane Prolyl 4 Hydroxylase (Volume, Value and Sales Price) by Players, Countries, Type and Application
    5.1 Africa Transmembrane Prolyl 4 Hydroxylase Sales and Value (2012-2017)
        5.1.1 Africa Transmembrane Prolyl 4 Hydroxylase Sales Volume and Growth Rate (2012-2017)
        5.1.2 Africa Transmembrane Prolyl 4 Hydroxylase Revenue and Growth Rate (2012-2017)
    5.2 Africa Transmembrane Prolyl 4 Hydroxylase Sales and Market Share by Type
    5.3 Africa Transmembrane Prolyl 4 Hydroxylase Sales and Market Share by Application
    5.4 Africa Transmembrane Prolyl 4 Hydroxylase Sales Volume and Value (Revenue) by Countries
        5.4.1 Africa Transmembrane Prolyl 4 Hydroxylase Sales Volume by Countries (2012-2017)
        5.4.2 Africa Transmembrane Prolyl 4 Hydroxylase Revenue by Countries (2012-2017)
        5.4.3 South Africa Transmembrane Prolyl 4 Hydroxylase Sales and Growth Rate (2012-2017)
        5.4.4 Nigeria Transmembrane Prolyl 4 Hydroxylase Sales and Growth Rate (2012-2017)
        5.4.5 Egypt Transmembrane Prolyl 4 Hydroxylase Sales and Growth Rate (2012-2017)
        5.4.6 Algeria Transmembrane Prolyl 4 Hydroxylase Sales and Growth Rate (2012-2017)

6 EMEA Transmembrane Prolyl 4 Hydroxylase Manufacturers/Players Profiles and Sales Data
    6.1 Bayer AG
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 Transmembrane Prolyl 4 Hydroxylase Product Type, Application and Specification
            6.1.2.1 Product A
            6.1.2.2 Product B
        6.1.3 Bayer AG Transmembrane Prolyl 4 Hydroxylase Sales, Revenue, Price and Gross Margin (2012-2017)
        6.1.4 Main Business/Business Overview
    6.2 FibroGen Inc
        6.2.1 Company Basic Information, Manufacturing Base and Competitors
        6.2.2 Transmembrane Prolyl 4 Hydroxylase Product Type, Application and Specification
            6.2.2.1 Product A
            6.2.2.2 Product B
        6.2.3 FibroGen Inc Transmembrane Prolyl 4 Hydroxylase Sales, Revenue, Price and Gross Margin (2012-2017)
        6.2.4 Main Business/Business Overview
    6.3 GlaxoSmithKline Plc
        6.3.1 Company Basic Information, Manufacturing Base and Competitors
        6.3.2 Transmembrane Prolyl 4 Hydroxylase Product Type, Application and Specification
            6.3.2.1 Product A
            6.3.2.2 Product B
        6.3.3 GlaxoSmithKline Plc Transmembrane Prolyl 4 Hydroxylase Sales, Revenue, Price and Gross Margin (2012-2017)
        6.3.4 Main Business/Business Overview
    6.4 Japan Tobacco Inc
        6.4.1 Company Basic Information, Manufacturing Base and Competitors
        6.4.2 Transmembrane Prolyl 4 Hydroxylase Product Type, Application and Specification
            6.4.2.1 Product A
            6.4.2.2 Product B
        6.4.3 Japan Tobacco Inc Transmembrane Prolyl 4 Hydroxylase Sales, Revenue, Price and Gross Margin (2012-2017)
        6.4.4 Main Business/Business Overview
    6.5 Sigmoid Pharma Ltd
        6.5.1 Company Basic Information, Manufacturing Base and Competitors
        6.5.2 Transmembrane Prolyl 4 Hydroxylase Product Type, Application and Specification
            6.5.2.1 Product A
            6.5.2.2 Product B
        6.5.3 Sigmoid Pharma Ltd Transmembrane Prolyl 4 Hydroxylase Sales, Revenue, Price and Gross Margin (2012-2017)
        6.5.4 Main Business/Business Overview
    6.6 Merck & Co., Inc.
        6.6.1 Company Basic Information, Manufacturing Base and Competitors
        6.6.2 Transmembrane Prolyl 4 Hydroxylase Product Type, Application and Specification
            6.6.2.1 Product A
            6.6.2.2 Product B
        6.6.3 Merck & Co., Inc. Transmembrane Prolyl 4 Hydroxylase Sales, Revenue, Price and Gross Margin (2012-2017)
        6.6.4 Main Business/Business Overview
    6.7 Akebia Therapeutics, Inc.
        6.7.1 Company Basic Information, Manufacturing Base and Competitors
        6.7.2 Transmembrane Prolyl 4 Hydroxylase Product Type, Application and Specification
            6.7.2.1 Product A
            6.7.2.2 Product B
        6.7.3 Akebia Therapeutics, Inc. Transmembrane Prolyl 4 Hydroxylase Sales, Revenue, Price and Gross Margin (2012-2017)
        6.7.4 Main Business/Business Overview
    ...

7 Transmembrane Prolyl 4 Hydroxylase Manufacturing Cost Analysis
    7.1 Transmembrane Prolyl 4 Hydroxylase Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of Transmembrane Prolyl 4 Hydroxylase

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 Transmembrane Prolyl 4 Hydroxylase Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of Transmembrane Prolyl 4 Hydroxylase Major Manufacturers in 2016
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 EMEA Transmembrane Prolyl 4 Hydroxylase Market Forecast (2017-2022)
    11.1 EMEA Transmembrane Prolyl 4 Hydroxylase Sales, Revenue and Price Forecast (2017-2022)
        11.1.1 EMEA Transmembrane Prolyl 4 Hydroxylase Sales and Growth Rate Forecast (2017-2022)
        11.1.2 EMEA Transmembrane Prolyl 4 Hydroxylase Revenue and Growth Rate Forecast (2017-2022)
        11.1.3 EMEA Transmembrane Prolyl 4 Hydroxylase Price and Trend Forecast (2017-2022)
    11.2 EMEA Transmembrane Prolyl 4 Hydroxylase Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.3 Europe Transmembrane Prolyl 4 Hydroxylase Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.4 Middle Eastt Transmembrane Prolyl 4 Hydroxylase Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.5 Africa Transmembrane Prolyl 4 Hydroxylase Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.6 EMEA Transmembrane Prolyl 4 Hydroxylase Sales Forecast by Type (2017-2022)
    11.7 EMEA Transmembrane Prolyl 4 Hydroxylase Sales Forecast by Application (2017-2022)

12 Research Findings and Conclusion

13 Appendix
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer